Targeting Non-V600 Mutations in BRAF: A Single Institution Retrospective Analysis and Review of the Literature

Abstract Background and Objective While successful treatment paradigms for BRAF V600 mutations have been developed, 10% of BRAF mutations are not at V600 and lack a standard treatment regimen. This study summarizes the current body of knowledge on the treatment of non-V600 mutations and reports a si...

Full description

Saved in:
Bibliographic Details
Main Authors: Hirra A. Chaudhary, Timothy L. Cannon, Arthur Winer
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-08-01
Series:Drugs in R&D
Online Access:https://doi.org/10.1007/s40268-024-00475-5
Tags: Add Tag
No Tags, Be the first to tag this record!